Early pregnancy triglycerides and blood pressure: a combined predictor for preeclampsia

Ying Zhu1, Hui Wang2, Si-Yi Wei1

  • 1Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, 200011, China.

PubMed

Insights

Early pregnancy elevated blood pressure and high triglyceride levels significantly increase preeclampsia risk. Combining stage 1 hypertension with high triglycerides poses a notable risk, highlighting a critical subgroup for clinical attention.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Health in Pregnancy
  • Maternal-Fetal Medicine

Background:

  • Elevated blood pressure and triglyceride (TG) levels are associated with adverse pregnancy outcomes.
  • While stage 2 hypertension is a known preeclampsia predictor, the impact of lower blood pressure categories requires further investigation.
  • Identifying early pregnancy risk factors is crucial for managing preeclampsia.

Purpose of the Study:

  • To evaluate the combined effect of early pregnancy blood pressure and TG levels on preeclampsia risk.
  • To identify a high-risk subgroup of pregnant individuals needing closer clinical monitoring.
  • To clarify the prognostic significance of different hypertension stages in conjunction with TG levels.

Main Methods:

  • Retrospective cohort study of 78,016 singleton births (Shanghai IPMCH, 2014-2019).
  • Participants classified by early pregnancy blood pressure (normotensive, elevated, stage 1, stage 2 hypertension) and TG levels (above/below 90th percentile).
  • Generalized additive and logistic regression models used to analyze associations.

Main Results:

  • Preeclampsia occurred in 2.83% of participants (2,204 cases).
  • Stage 1 and stage 2 hypertension significantly increased preeclampsia risk (AORs 3.40 and 6.96, respectively).
  • High TG levels amplified preeclampsia risk across all blood pressure categories, with synergistic risk observed for stage 1 hypertension and high TG (OR 1.50).

Conclusions:

  • The combination of elevated blood pressure and high TG levels, particularly with stage 1 or 2 hypertension, substantially increases preeclampsia risk.
  • Stage 1 hypertension co-occurring with high TG levels represents a significant risk factor, comparable to stage 2 hypertension alone.
  • Early identification of this combined risk profile is essential for targeted clinical intervention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
298
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
58